|
[1]
|
MORROW R J�� WOOLFSON A D�� DONNELL Y�� et al. Sustained release of proteins from a modified vaginal ring device[J]. EurJ Pharm Biopharm�� 2011�� 77(1)�� 3-10.
|
|
[2]
|
MANONAI J�� THEPPISAI U�� CHITTAEHAROEN A. Effect and safety of 17-beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms[J]. J Med Assoc Thai�� 2001�� 84 (7)�� 1015-1020.
|
|
[3]
|
MANONAI J�� THEPPISAI U�� SUTHUTVORAVUT S�� et al. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women�� a comparative study[J]. J Obstet Gynaecol Res�� 2001�� 27 (5)�� 255-260.
|
|
[4]
|
CHANRACHAKUL B�� HERABUTYA Y�� PUNYAVACHIRA P. Randomized comparison of glyceryl trinitrate and prostaglandin E2 for cervicav ripening at term[J]. Obstet Gynecol�� 2000�� 9 (4)�� 549-553.
|
|
[5]
|
PETERSEN E E�� MAGNANI P. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis�� a randomized��double blind�� placebo-controlled study[J]. Eur J Obstet Gynecol Reprod Biol�� 2004�� 117(1)�� 70-75.
|
|
[6]
|
KHOURY A N�� ZHOU Q P�� GORENBERG D M�� et al. A comparison of intermittent vaginal administration of two different doses of misoprostol suppositories with continuous dinoprostone for cervical ripening and labor induction[J]. J Matern Fetal Neonatal Med�� 2001�� 10 (3)�� 186-192.
|
|
[7]
|
DCRUZ O J�� UCKUN F M. Gel microemulsions as vaginal spermicides and intravaginal drug delivery vehicles[J]. Contraception�� 2001�� 64 (2)�� 113-123.
|
|
[8]
|
RABL M�� JOURA E A�� YUCEL Y�� et al. A randomized trial of vaginal prostaglandin E2 for induction of labor�� insert vs tablet[J]. J Reprod Med�� 2002�� 47 (2)�� 115-119.
|
|
[9]
|
NOVA′K A�� DE LA LOGE C�� ABETZ L�� et al. The combined contraceptive vaginal ring�� NuvaRing��an international study of user acceptability[J]. Contraception�� 2003�� 67��3���� 187-194.
|
|
[10]
|
MULDERS T M�� DIEBEN T O. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition[J]. Fertil Steril�� 2001�� 75 (5)�� 865-870.
|
|
[11]
|
ROUMEN F J M E�� APTER D�� MULDERS T M T�� et al. Efficacy�� tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol[J]. Hum Reprod�� 2001�� 16 (3)�� 469-475.
|
|
[12]
|
SALTZMAN W M�� SHERWOOD J K�� ADAMS D R�� et al. Long-term vaginal antibody delivery�� delivery systems and biodistribution[J]. Biotechnol Bioeng�� 2000�� 67 (3)�� 253-264.
3.0.CO;2-T target="_blank">
|
|
[13]
|
SIMON J A. Identifying and treating sexual dysfunction in postmenopausal women�� the role of Estrogen[J]. J Womens Health�� 2011�� 20(10)�� 1453-1465.
|
|
[14]
|
LYER V�� PODDAR S S. Formulation and modulation of drug release from an intra vaginal ring[J]. Indian J Pharml Educ�� 2009�� 43(2)�� 117-124.
|
|
[15]
|
BULTER S E�� SRINIVASAN P�� LOWERY D�� et al. Progesterone release from a silicone intravaginal ring in pig tailed macaques[J]. J Med Primatol�� 2011�� 40(4)�� 269.
|
|
[16]
|
AHMED S U�� CHOWDHURY�� TAISEEN A�� et al. Flexible compressed in travaginal rings�� methods of making and using the same�� and apparatus for making the same�� United States�� US07910126[P]. 2011-3-22.
|
|
[17]
|
MASHAK A�� RAHIMI A. Silicone polymers in controlled drug delivery systems��A review[J]. Iran Polym J�� 2009�� 18(4)�� 279-295.
|
|
[18]
|
SRINIVASAN P�� JOHNSON T�� MARTIN A�� et al. Vaginal release kinetics of pyrimidinedione IQP-0528 from a polurethane intravaginal ring[J]. J Med Primatolo�� 2011�� 40(4)�� 249-285.
|
|
[19]
|
KAUR M�� GUPTA K M�� POURSAID A E�� et al. Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine[J]. Drug Deliv Trans Res�� 2011�� 1(3)�� 223-237.
|
|
[20]
|
JOHNSON T J�� GUPTA K M�� FABIAN J�� et al. Segement polyurethane intravaginal rings for intravaginal ring for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir[J]. Eur J Pharm Sci�� 2010�� 41(5)�� 736.
|
|
[21]
|
COLAS A. Silicones in pharmaceutical applications[J/OL]. Dow Corning Healthcare Industries�� Belgium.2001�� No.51-993A-01. http��//www.dowcorning.com/content/publishedlit/51-993a-01.pdf
|
|
[22]
|
WOOLFSON A D�� MALCOLM R K�� GALLAGHER R J. Design of a silicone reservoir intravaginal ring for the delivery of oxybutynin[J]. J Controlled Release�� 2003�� 91 (3)�� 465-476.
|
|
[23]
|
YANG Y S�� PENG H Y�� QI G R�� et al. Diffusion mechanism of through sem-crystalline ethylene-venyl acetate copolymer�� free volume theory[J]. Acata Polomerica Sinica(�߷���ѧ��)�� 2002�� 1 (2)�� 242-244.
|
|
[24]
|
WANG Q�� SHAO B�� CHEN G S. Effects of EVAc membrane and enhancers on levonorgestrel permeation rate through human skin[J]. Chin Pharm J(�й�ҩѧ��־)�� 1998�� 33 (11)�� 665-668.
|
|
[25]
|
VAN LAARHOVEN J A�� KRUFT M A�� VROMANS H. In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring[J]. Indian J Pharmacol�� 2002�� 232 (1-2)�� 163-173.
|
|
[26]
|
SZYCHER M. Biostability of polyurethane elastomers�� a critical review[J]. J Biomater Appl�� 1988�� 3 (2)�� 297-402.
|
|
[27]
|
JOHNSON T J�� GUPTA K M�� FABIAN J�� et al. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir[J]. Egypt J Pharm Sci�� 2010�� 39 (4)�� 203-212.
|
|
[28]
|
GUPTA K M�� PEARCE S M�� POURSAID A E�� et al. Polyurethane intravaginal ring for controlled delivery of dapivirine�� a nonnucleoside reverse transcriptase inhibitor of HIV-1[J]. J Pharm Sci�� 2008�� 97 (10)�� 4228-4239.
|
|
[29]
|
YOON S C��RATNER B D. Surface and bulk structure of segmented poly(ether urethanes) with perfluoro chain extenders. Effects of annealing�� casting�� solvent�� and casting conditions[J]. Macromolecules�� 1988�� 21 (8)�� 2401-2404.
|
|
[30]
|
VERMETTE P�� GRIESSER H J�� LAROCHE G�� et al. Biomedical Applications of Polyurethanes[M]. Georgetown�� Texas�� U S A�� Eurekah.com/Landes Bioscience�� 2001�� August 21.
|
|
[31]
|
JOHANSSON E�� SITRUK-WARE R. New delivery systems in contraception�� vaginal rings[J]. Am J Obstet Gynecol�� 2004�� 190 (4�� suppl 1)��54-59.
|
|
[32]
|
VARTIAINEN J�� WAHLSTROM T�� NILSSON C G. Effects and acceptability of a new 17 beta-oestradiol-releasing vaginal ring in the treatment of postmenopausal complaints[J]. Maturitas�� 1993�� 17(2)�� 129-137.
|
|
[33]
|
HAN Y A�� SINGH M�� SAXENA B B. Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents[J].Contraception�� 2007�� 76(2)�� 132-138.
|
|
[34]
|
SAXENA B B�� HAN Y A�� FU D Y�� et al. Sustained release of microbicides by newly engineered vaginal rings[J]. AIDS�� 2009�� 15(6)�� 917-922.
|
|
[35]
|
NATH A�� SITRUK-WARE R. Progesterone vaginal ring for contraceptive use during lactation[J]. Contraception�� 2010�� 82��5���� 428-434.
|
|
[36]
|
Reproductive health suppliers coalition. Progesterone-only vaginal ring[J/OL]. Caucus�� Washington�� DC�� USA. 2011-1. http��//www.path.org/files/RHSC_povr_br.pdf
|
|
[37]
|
The Population Council Inc. Building on decades of success�� poineering contraceptive research and products[J/OL]. New York�� USA. Population Council�� 2010-11. http��//www.popcouncil.org/pdfs/factsheets/RH_ContraceptiveDev. pdf
|
|
[38]
|
MALCOLM R K�� EDWARDS K L�� KISER P�� et al. Advances in microbicide vaginal rings[J]. Antiviral Res�� 2010�� 88(suppl)�� 30-39.
|
|
[39]
|
WOOLFSON A D�� MALCOLM R K�� GALLAGHER R J. Design of a silicone reservoir intravaginal ring for the delivery of oxybutynin[J]. J Controlled Release�� 2003�� 91(3)�� 465-476.
|
|
[40]
|
WOOLFSON A D�� MALCOLM R K. Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble d
|
2012, Vol. 47 